142 related articles for article (PubMed ID: 30073765)
21. An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes.
Buchanan K; Mehdi AM; Hughes I; Cotterill A; Le Cao KA; Thomas R; Harris M
Pediatr Diabetes; 2019 Mar; 20(2):166-171. PubMed ID: 30556344
[TBL] [Abstract][Full Text] [Related]
22. Comparison of proinsulin and C-peptide secretion in healthy versus long-standing type 1 diabetes mellitus cohorts: A pilot study.
Sullivan CA; Cacicedo JM; Rajendran I; Steenkamp DW
PLoS One; 2018; 13(11):e0207065. PubMed ID: 30412637
[TBL] [Abstract][Full Text] [Related]
23. Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNA.
Okada A; Yamada-Yamashita M; Tominaga Y; Jo K; Mori H; Suzuki R; Ishizu M; Tamaki M; Akehi Y; Takashi Y; Koga D; Shimokita E; Tanihara F; Kurahashi K; Yoshida S; Mitsui Y; Masuda S; Endo I; Aihara KI; Kagami S; Abe M; Ferreri K; Fujitani Y; Matsuhisa M; Kuroda A
J Diabetes Investig; 2022 Jul; 13(7):1140-1148. PubMed ID: 35396829
[TBL] [Abstract][Full Text] [Related]
24. Residual C-peptide in type 1 diabetes: what do we really know?
VanBuecken DE; Greenbaum CJ
Pediatr Diabetes; 2014 Mar; 15(2):84-90. PubMed ID: 24645775
[TBL] [Abstract][Full Text] [Related]
25. Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes.
Watkins RA; Evans-Molina C; Terrell JK; Day KH; Guindon L; Restrepo IA; Mirmira RG; Blum JS; DiMeglio LA
Transl Res; 2016 Feb; 168():96-106.e1. PubMed ID: 26397425
[TBL] [Abstract][Full Text] [Related]
26. Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.
Pham MN; Kolb H; Battelino T; Ludvigsson J; Pozzilli P; Zivehe F; Roden M; Mandrup-Poulsen T; Schloot NC;
Diabetologia; 2013 Jun; 56(6):1356-63. PubMed ID: 23494449
[TBL] [Abstract][Full Text] [Related]
27. Metabolic Characteristics of Recently Diagnosed Adult-Onset Autoimmune Diabetes Mellitus.
Zaharia OP; Bobrov P; Strassburger K; Bódis K; Karusheva Y; Scholz M; Markgraf DF; Burkart V; Schloot NC; Müssig K; Szendroedi J; Roden M;
J Clin Endocrinol Metab; 2018 Feb; 103(2):429-437. PubMed ID: 29220505
[TBL] [Abstract][Full Text] [Related]
28. Residual β cell function and monogenic variants in long-duration type 1 diabetes patients.
Yu MG; Keenan HA; Shah HS; Frodsham SG; Pober D; He Z; Wolfson EA; D'Eon S; Tinsley LJ; Bonner-Weir S; Pezzolesi MG; King GL
J Clin Invest; 2019 Jul; 129(8):3252-3263. PubMed ID: 31264968
[TBL] [Abstract][Full Text] [Related]
29. Residual β-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes.
Sorensen JS; Birkebaek NH; Bjerre M; Pociot F; Kristensen K; Hoejberg AS; Frystyk J;
J Clin Endocrinol Metab; 2015 Mar; 100(3):1053-61. PubMed ID: 25532040
[TBL] [Abstract][Full Text] [Related]
30. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells.
Oram RA; Jones AG; Besser RE; Knight BA; Shields BM; Brown RJ; Hattersley AT; McDonald TJ
Diabetologia; 2014 Jan; 57(1):187-91. PubMed ID: 24121625
[TBL] [Abstract][Full Text] [Related]
31. Circulating immune mediators are closely linked in adult-onset type 1 diabetes as well as in non-diabetic subjects.
Fleiner HF; Radtke M; Ryan L; Moen T; Grill V
Autoimmunity; 2014 Dec; 47(8):530-7. PubMed ID: 25027869
[TBL] [Abstract][Full Text] [Related]
32. Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes.
Husseiny MI; Kuroda A; Kaye AN; Nair I; Kandeel F; Ferreri K
PLoS One; 2012; 7(10):e47942. PubMed ID: 23144715
[TBL] [Abstract][Full Text] [Related]
33. Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell loss.
Xu G; Thielen LA; Chen J; Grayson TB; Grimes T; Bridges SL; Tse HM; Smith B; Patel R; Li P; Evans-Molina C; Ovalle F; Shalev A
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E723-E730. PubMed ID: 31408375
[TBL] [Abstract][Full Text] [Related]
34. Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata.
Wasserfall C; Nick HS; Campbell-Thompson M; Beachy D; Haataja L; Kusmartseva I; Posgai A; Beery M; Rhodes C; Bonifacio E; Arvan P; Atkinson M
Cell Metab; 2017 Sep; 26(3):568-575.e3. PubMed ID: 28877460
[TBL] [Abstract][Full Text] [Related]
35. C-peptide antioxidant adaptive pathways in β cells and diabetes.
Luppi P; Drain P
J Intern Med; 2017 Jan; 281(1):7-24. PubMed ID: 27251308
[TBL] [Abstract][Full Text] [Related]
36. Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetes.
DiMeglio LA; Cheng P; Beck RW; Kollman C; Ruedy KJ; Slover R; Aye T; Weinzimer SA; Bremer AA; Buckingham B;
Pediatr Diabetes; 2016 Jun; 17(4):237-43. PubMed ID: 25720763
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy.
Agardh E; Lundstig A; Perfilyev A; Volkov P; Freiburghaus T; Lindholm E; Rönn T; Agardh CD; Ling C
BMC Med; 2015 Aug; 13():182. PubMed ID: 26248552
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis.
Tosur M; Cleves MA; Sosenko JM; Libman I; Baidal DA; Balasubramanyam A; Redondo MJ;
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4393-406. PubMed ID: 32502242
[TBL] [Abstract][Full Text] [Related]
39. Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration.
Lindström T; Frystyk J; Hedman CA; Flyvbjerg A; Arnqvist HJ
Clin Endocrinol (Oxf); 2006 Dec; 65(6):776-82. PubMed ID: 17121530
[TBL] [Abstract][Full Text] [Related]
40. Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide.
Espes D; Singh K; Sandler S; Carlsson PO
Diabetes Care; 2017 Aug; 40(8):1090-1095. PubMed ID: 28620093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
